dc.contributor.author |
Thomas, Ioannis |
|
dc.contributor.author |
Leiter-Stöppke, Ulrike |
|
dc.contributor.author |
Eigentler, Thomas |
|
dc.date.accessioned |
2025-08-25T07:05:51Z |
|
dc.date.available |
2025-08-25T07:05:51Z |
|
dc.date.issued |
2023 |
|
dc.identifier.issn |
0140-6736 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/169421 |
|
dc.identifier.uri |
http://dx.doi.org/10.15496/publikation-110748 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
New York : Elsevier Science Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/S0140-6736(23)00769-9 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20240124000000_01455 |
|
utue.publikation.seiten |
798-808 |
de_DE |
utue.personen.roh |
Becker, Joergen C. |
|
utue.personen.roh |
Ugurel, Selma |
|
utue.personen.roh |
Leiter, Ulrike |
|
utue.personen.roh |
Meier, Friedegund |
|
utue.personen.roh |
Gutzmer, Ralf |
|
utue.personen.roh |
Haferkamp, Sebastian |
|
utue.personen.roh |
Zimmer, Lisa |
|
utue.personen.roh |
Livingstone, Elisabeth |
|
utue.personen.roh |
Eigentler, Thomas K. |
|
utue.personen.roh |
Hauschild, Axel |
|
utue.personen.roh |
Kiecker, Felix |
|
utue.personen.roh |
Hassel, Jessica C. |
|
utue.personen.roh |
Mohr, Peter |
|
utue.personen.roh |
Fluck, Michael |
|
utue.personen.roh |
Thomas, Ioannis |
|
utue.personen.roh |
Garzarolli, Marlene |
|
utue.personen.roh |
Grimmelmann, Imke |
|
utue.personen.roh |
Drexler, Konstantin |
|
utue.personen.roh |
Spillner, Alexandra N. |
|
utue.personen.roh |
Eckhardt, Sebastian |
|
utue.personen.roh |
Schadendorf, Dirk |
|
dcterms.isPartOf.ZSTitelID |
Lancet |
de_DE |
dcterms.isPartOf.ZS-Issue |
10404 |
de_DE |
dcterms.isPartOf.ZS-Volume |
402 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |